Profound Medical (TSX:PRN) EV-to-Revenue : 23.14 (As of May. 08, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Profound Medical EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Profound Medical's enterprise value is C$224.64 Mil. Profound Medical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was C$9.71 Mil. Therefore, Profound Medical's EV-to-Revenue for today is 23.14.

The historical rank and industry rank for Profound Medical's EV-to-Revenue or its related term are showing as below:

TSX:PRN' s EV-to-Revenue Range Over the Past 10 Years
Min: 4.51 Med: 25.34 Max: 77.19
Current: 23.14

During the past 10 years, the highest EV-to-Revenue of Profound Medical was 77.19. The lowest was 4.51. And the median was 25.34.

TSX:PRN's EV-to-Revenue is ranked worse than
91.15% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: 3.22 vs TSX:PRN: 23.14

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-08), Profound Medical's stock price is C$10.22. Profound Medical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.46. Therefore, Profound Medical's PS Ratio for today is 22.31.

Profound Medical EV-to-Revenue Historical Data

The historical data trend for Profound Medical's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Profound Medical EV-to-Revenue Chart

Profound Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

30.89

45.31

24.11

27.58

22.02

Profound Medical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															27.58	22.69	35.14	29.42	22.02

Competitive Comparison of Profound Medical's EV-to-Revenue

For the Medical Devices subindustry, Profound Medical's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Profound Medical's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Profound Medical's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Profound Medical's EV-to-Revenue falls into.

Profound Medical EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Profound Medical's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	224.644	/	9.706
	=	23.14

Profound Medical's current Enterprise Value is C$224.64 Mil.
Profound Medical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$9.71 Mil.

Profound Medical (TSX:PRN) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Profound Medical's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	10.22	/	0.458
	=	22.31

Profound Medical's share price for today is C$10.22.
Profound Medical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.46.

Profound Medical EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Profound Medical's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Profound Medical (TSX:PRN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Profound Medical Corp (TSX:PRN) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

PROF:USA

Address

2400 Skymark Avenue, Unit 6, Mississauga, ON, CAN, L4W 5K5

Website

https://www.profoundmedical.com

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.